An interpretable XAI deep EEG model for schizophrenia diagnosis using feature selection and attention mechanisms
Frontiers in Oncology · 22.07.2025 · 15
DOI: 10.3389/fonc.2025.1630291 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Oncology, online erschienen am 22.07.2025. Verfasst von Ahmad Almadhor und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Computer Engineering and Networks, College of Computer and Information Sciences, Jouf University, Sakaka, Saudi Arabia. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deanship of Scientific Research, King Khalid University.
Abstract (Originalsprache)
Introduction
Schizophrenia is a severe psychological disorder that significantly impacts an individual’s life and is characterized by abnormalities in perception, behavior, and cognition. Conventional Schizophrenia diagnosis techniques are time- consuming and prone to error. The study proposes a novel automated technique for diagnosing Schizophrenia based on electroencephalogram (EEG) sensor data, aiming to enhance interpretability and prediction performance.
Methods
This research utilizes Deep Learning (DL) models, including the Deep Neural Network (DNN), Bi-Directional Long Short-Term Memory-Gated Recurrent Unit (BiLSTM- GRU), and BiLSTM with Attention, for the detection of Schizophrenia based on EEG data. During preprocessing, SMOTE is applied to address the class imbalance. Important EEG characteristics that influence model decisions are highlighted by the interpretable BiLSTM-Attention model using attention weights in conjunction with SHAP and LIME explainability tools. In addition to fine-tuning input dimensionality, F-test feature selection increases learning efficiency.
Results
Through the integration of feature importance analysis and conventional performance measures, this study presents valuable insights into the discriminative neurophysiological patterns associated with Schizophrenia, advancing both diagnostic and neuroscientific expertise. The experiment’s findings show that the BiLSTM with attention mechanism model provides and accuracy of 0.68%.
Discussion
The results show that the recommended approach is useful for Schizophrenia diagnosis.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Computer Engineering and Networks, College of Computer and Information Sciences, Jouf University, Sakaka, Saudi Arabia.
- Department of Electrical and Computer Engineering, College of Engineering, Anderson University, Anderson, SC, United States.
- School of Medicine Greenville, University of South Carolina, Greenville, SC, United States.
- College of Computer Engineering and Sciences, Prince Sattam bin Abdulaziz University, AlKharj, Saudi Arabia.
- Department of Electrical Engineering, King Khalid University, Abha, Saudi Arabia.
- Computer Science Department, Faculty of Computers & Information Technology, University of Tabuk, Tabuk, Saudi Arabia.
Förderung
- Deanship of Scientific Research, King Khalid University
Zitieren
APA
Almadhor, A., Ojo, S., Nathaniel, T. I., Alsubai, S., Alharthi, A., Hejaili, A. A., & Sampedro, G. A. (2025). An interpretable XAI deep EEG model for schizophrenia diagnosis using feature selection and attention mechanisms. Frontiers in Oncology, 15. https://doi.org/10.3389/fonc.2025.1630291
Vancouver
Almadhor A, Ojo S, Nathaniel TI, Alsubai S, Alharthi A, Hejaili AA, et al. An interpretable XAI deep EEG model for schizophrenia diagnosis using feature selection and attention mechanisms. Frontiers in Oncology. 2025;15. doi:10.3389/fonc.2025.1630291
BibTeX
@article{Almadhor2025,
author = {Almadhor, Ahmad and Ojo, Stephen and Nathaniel, Thomas I and Alsubai, Shtwai and Alharthi, Abdullah and Hejaili, Abdullah Al and Sampedro, Gabriel Avelino},
title = {An interpretable XAI deep EEG model for schizophrenia diagnosis using feature selection and attention mechanisms},
journal = {Frontiers in Oncology},
year = {2025},
volume = {15},
doi = {10.3389/fonc.2025.1630291}
}
EUVIMED